Insitro is an operator of a data-driven drug discovery and development company that utilizes machine learning and high-throughput biology to transform the way that drugs are discovered and delivered to patients.

The company uses state-of-the-art technologies from bioengineering enabling it to generate high-throughput, functional genomic data sets